Read More Pharma Industry News PTC Therapeutics collaborates with Royalty Pharma in $1.5bn Evrysdi royalty agreement PTC Therapeutics, Inc. (NASDAQ: PTCT) has forged an agreement with Royalty Pharma plc., monetizing up to a staggering… byPallavi MadhirajuOctober 19, 2023